Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
ATLANTA, September 11, 2023 — In a new study led by researchers at the American Cancer Society (ACS), most adults (73.2 %) in the United States overdue for colorectal cancer screening (CRC)...
The study showed that 55% of CRC patients in SSA survived two years after a diagnosis of their disease, compared to 84% of patients in the United States, and the risk of dying from CRC was 67% higher in patients diagnosed in low-income countries than those diagnosed in middle-income countries.
Prostate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with the disease this year, with close to 35,000 deaths. Black men are two times more likely to die from the disease than White men and have the highest death rate for prostate cancer of any racial and ethnic group. However, when prostate cancer is detected early, the odds of survival are high.
BrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm, published its most recent annual report, featuring how its portfolio of 18 companies has the potential to improve the lives of more than 1.5 million cancer patients and their families.
HONOLULU, HAWAIʻI, August 15, 2023 – Nearly 8,500 Hawaiʻi residents are expected to be diagnosed with cancer this year and thousands of others are living with the disease. The recent wildfire...